Wanbangde Pharmaceutical Holding Group Co Ltd (002082) — Cash Flow Quality Index
Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Cash Flow Quality Index of -0.97x as of March 2025. Operating cash flow of CN¥-14.73 Million is below net income of CN¥15.20 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Wanbangde Pharmaceutical Holding Group C to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow Quality Index (2003–2024)
Historical Cash Flow Quality Index for Wanbangde Pharmaceutical Holding Group Co Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 002082 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2024)
Year-by-year earnings quality comparison for Wanbangde Pharmaceutical Holding Group Co Ltd. For live market cap and the full company financial profile, see 002082 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.66x | CN¥120.22 Million | CN¥45.25 Million | ▲ +196.0% |
| 2023 | -2.77x | CN¥-72.87 Million | CN¥26.33 Million | ▲ +14.2% |
| 2022 | -3.22x | CN¥-239.65 Million | CN¥74.32 Million | ▼ -2452.9% |
| 2021 | 0.14x | CN¥22.09 Million | CN¥161.16 Million | ▼ -73.5% |
| 2020 | 0.52x | CN¥151.01 Million | CN¥292.21 Million | ▲ +143.4% |
| 2019 | -1.19x | CN¥-248.69 Million | CN¥208.83 Million | ▼ -210.1% |
| 2018 | 1.08x | CN¥135.40 Million | CN¥125.19 Million | ▲ +716.9% |
| 2017 | -0.18x | CN¥-17.60 Million | CN¥100.41 Million | ▼ -104.1% |
| 2016 | 4.23x | CN¥310.71 Million | CN¥73.38 Million | ▲ +1628.5% |
| 2015 | 0.24x | CN¥16.76 Million | CN¥68.43 Million | ▼ -80.2% |
| 2014 | 1.24x | CN¥140.31 Million | CN¥113.35 Million | ▼ -38.1% |
| 2013 | 2.00x | CN¥234.35 Million | CN¥117.26 Million | ▼ -10.3% |
| 2012 | 2.23x | CN¥202.73 Million | CN¥90.94 Million | ▲ +25304.7% |
| 2011 | -0.01x | CN¥-1.44 Million | CN¥162.46 Million | ▼ -100.8% |
| 2010 | 1.04x | CN¥162.26 Million | CN¥155.48 Million | ▲ +88.5% |
| 2009 | 0.55x | CN¥68.13 Million | CN¥123.08 Million | ▼ -83.5% |
| 2008 | 3.35x | CN¥253.06 Million | CN¥75.54 Million | ▲ +1649.1% |
| 2007 | 0.19x | CN¥12.45 Million | CN¥65.02 Million | ▲ +101.5% |
| 2006 | 0.10x | CN¥3.50 Million | CN¥36.84 Million | ▼ -82.6% |
| 2005 | 0.55x | CN¥11.23 Million | CN¥20.56 Million | ▼ -56.8% |
| 2004 | 1.26x | CN¥32.69 Million | CN¥25.85 Million | ▼ -30.9% |
| 2003 | 1.83x | CN¥37.01 Million | CN¥20.23 Million | — |